课题基金 / 基金详情

Addressing the architecture, dynamics and activation mechanism of the CGRP receptor

Addressing the architecture, dynamics and activation mechanism of the CGRP receptor
解决 CGRP 受体的结构、动力学和激活机制
批准号:
BB/M007529/1
负责人:
David Poyner
金额:
$43.45万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

David Poyner的其他基金

相似基金

相关文献

中文摘要
翻译
G蛋白偶联受体(GPCRs)是人类基因组中最大的蛋白质家族,也是治疗药物的最大靶点,因此具有巨大的科学价值和实用价值。他们被分成几个家庭。其中,A家族是最了解的,但B家族包括可能在许多疾病状态下很重要的受体,因此了解这些受体是如何发挥作用是很重要的,这既是为了进一步了解基础生物学知识,也是为了设计新药。降钙素基因相关肽(CGRP)广泛存在于神经系统中,在调节心血管系统(心脏和血管)以及免疫系统和炎症方面特别重要。CGRP的受体具有特殊的科学意义,因为它涉及一种名为CLR的GPCR,以及另一种名为RAMP1的蛋白质。RAMP1是调节许多GPCR的蛋白质家族的成员,其中最具特征的是CLR。CGRP在心血管疾病和任何涉及炎症的疾病中也可能是重要的。这种多肽是偏头痛的主要原因,阻断CGRP受体的药物在临床试验中显示出巨大的前景;然而,到目前为止,由于毒性问题,这些药物还不可能用于临床。因此,迫切需要开发能够作用于CGRP受体的新药。CGRP受体由两部分组成。在细胞膜中发现了一种称为跨膜结构域的部分。这与细胞外的胞外区相连。CGRP与这一结构的两个部分相互作用,导致跨膜结构域改变形状。这会导致受体与其他蛋白质相互作用,导致细胞激活。我们有一个位于细胞外部的CGRP受体部分的晶体结构。不幸的是,我们不知道CGRP如何与此结合,也不知道它如何与跨膜结构域结合。这严重限制了我们对该受体的了解,以及我们设计针对该受体的药物的能力。我们之前曾使用一种名为定点突变的技术的实验数据来构建CGRP受体跨膜域的计算机模型。该跨膜结构域与两个B家族GPCR的跨膜结构域非常相似,这两个家族GPCR在我们的计算机模型产生后结晶。这让我们相信,我们将实验方法和计算方法结合起来的方法是有价值的。在这个项目中,我们打算扩展方法来研究CGRP如何与受体的两个区域结合,以及这如何导致受体被激活。我们将使用突变和我们物理上将CGRP与受体交联的方法来确定接触点。然后我们将使用它们来构建计算模型,我们可以通过进一步的实验来改进这些模型。使用计算机,我们可以预测当CGRP与受体结合时,受体的形状将如何变化,从而确定受体激活的机制。这些知识将有益于新药的设计,这些新药可以阻断受体或促进其激活。
英文摘要
G protein coupled receptors (GPCRs) are the largest family of proteins in the human genome and also the largest target for therapeutic drugs; thus they are of enormous scientific and practical interest. They are divided into a number of families. Of these, family-A is the best understood, but family-B includes receptors which are likely to be important in many disease states and so it is important to understand how these function, both to further our knowledge of fundamental biology and also for the design of new drugs.Calcitonin gene-related peptide (CGRP) is found throughout the nervous system and is particularly important in regulating both the cardiovascular system (the heart and blood vessels) and also the immune system and inflammation. The receptor for CGRP is of special scientific interest as it involves a GPCR called CLR and also a second protein called RAMP1. RAMP1 is a member of a protein family that modulates a number of GPCRs of which the best characterised is CLR. CGRP is also likely to be important both in cardiovascular disorders and any disease that involves inflammation. The peptide is a major cause of migraine and drugs which block CGRP receptors have shown great promise in clinical trials; however, so far it has not been possible to use these clinically because of toxicity problems. Thus, there is an urgent need to develop new drugs that could act on CGRP receptors.The CGRP receptor is made up of two parts. A portion called the transmembrane domain is found in the membranes of cells. This is connected to the extracellular domain, which is on the outside of cells. CGRP interacts with both parts of this structure and causes the transmembrane domain to change shape. This causes the receptor to interact with other proteins, leading to cell activation. We have a crystal structure of the part of the CGRP receptor that is on the outside of cells. Unfortunately, we do not know how CGRP binds to this, nor do we know how it binds to the transmembrane domain. This severely limits our understanding of the receptor and our ability to design drugs that could target it.We have previously used experimental data from a technique known as site-directed mutagenesis to construct a computer model of the transmembrane domain of the CGRP receptor. This transmembrane domain is very similar to the transmembrane domains of two family-B GPCRs which were crystallised after our computer model was produced. This gives us confidence that our approach of combining experimental and computational methods is valuable. In this project, we intend to extend the approach to study how CGRP binds to both domains of the receptor and how this causes the receptor to become activated. We will use mutagenesis and also methods where we physically cross-link CGRP to the receptor to identify contact points. We will then use these to construct computational models, which we can refine through further experimentation. Using a computer, we can predict how the receptor shape will change when CGRP binds to it, so identifying the mechanism for receptor activation. This knowledge will be benefitial in the design of new drugs which can either block the receptor or promote its activation.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1084/jem.20180528
发表时间: 2018-09-03
期刊: The Journal of experimental medicine
影响因子: --
作者: [Mackie DI, Al Mutairi F, Davis RB, Kechele DO, Nielsen NR, Snyder JC, Caron MG, Kliman HJ, Berg JS, Simms J, Poyner DR, Caron KM]
通讯作者: Caron KM
DOI: 10.1021/acs.biochem.8b00502
发表时间: 2018-07
期刊: Biochemistry
影响因子: 2.9
作者: [J. Simms;Romez Uddin;T. Sakmar;Joseph J Gingell;Michael L Garelja;D. Hay;M. Brimble;P. Harris;C. Reynolds;D. Poyner]
通讯作者: J. Simms;Romez Uddin;T. Sakmar;Joseph J Gingell;Michael L Garelja;D. Hay;M. Brimble;P. Harris;C. Reynolds;D. Poyner
DOI: 10.1007/164_2018_132
发表时间: 2018-05
期刊: Handbook of experimental pharmacology
影响因子: --
作者: [J. Simms;S. Routledge;Romez Uddin;D. Poyner]
通讯作者: J. Simms;S. Routledge;Romez Uddin;D. Poyner
DOI: 10.1016/j.bcp.2018.02.005
发表时间: 2018-04
期刊: Biochemical pharmacology
影响因子: 5.8
作者: [Dal Maso E, Zhu Y, Pham V, Reynolds CA, Deganutti G, Hick CA, Yang D, Christopoulos A, Hay DL, Wang MW, Sexton PM, Furness SGB, Wootten D]
通讯作者: Wootten D
共 6 条
    Investigating GPCR:RAMP interactions using nanobodies
    • 批准号:
      BB/R016755/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $3.57万
    • 财政年份:
      2018
    • 负责人:
      David Poyner
    • 依托单位:
    A new method of in-silico drug discovery using essential dynamics
    • 批准号:
      BB/S000100/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $1.2万
    • 财政年份:
      2018
    • 负责人:
      David Poyner
    • 依托单位:
    THE ROLE OF RAMPS IN LIGAND-ENGENDERED SIGNAL BIAS OF SECRETIN-LIKE RECEPTORS
    • 批准号:
      BB/M000176/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $3.94万
    • 财政年份:
      2015
    • 负责人:
      David Poyner
    • 依托单位:
    The Use Of Novel Polymer-Lipid Nanoparticles To Study G-Protein-Coupled Receptor Activation And Dynamics
    • 批准号:
      BB/I019960/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $38.65万
    • 财政年份:
      2012
    • 负责人:
      David Poyner
    • 依托单位:
    国内基金
    海外基金
    The formation and evolution of planetary systems in dense star clusters
    • 批准号:
      11043007
    • 项目类别:
      专项基金项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2010
    • 负责人:
      柯文采
    • 依托单位: